AstraZeneca to work on vaccine combinations with Sputnik developer

Britain's AstraZeneca on Friday said that it will begin work with Russia's Gamaleya Institute to understand whether their two COVID-19 vaccine candidates can be successfully combined.

The Gamaleya Institute is the developer of Russia's Sputnik V vaccine.